The AFES-ESROC-KES Joint Symposium focuses on the latest advancements in thyroid disease, bringing together experts from the ASEAN Federation of Endocrine Societies (AFES), the Endocrine Society of the Republic of China (ESROC), and the Korean Endocrine Society (KES). This symposium serves as a platform for discussing cutting-edge research, clinical innovations, and regional perspectives on thyroid disorders. Through expert presentations and in-depth discussions, the symposium aims to enhance collaboration, drive scientific progress, and improve patient care in the field of thyroid disease.

The ESA-KES joint symposium will address misconceptions about anti-resorptive agents and discuss practical treatment strategies. Professor Christian Girgis will present insights on denosumab discontinuation, Professor Sung Hye Kong will examine its necessity in dental procedures, and Professor Hanh Nguyen will discuss managing atypical femur fractures. This session will provide key updates and clinical insights on osteoporosis treatment.

Aligned with SICEM 2025's theme, "Facing the Challenges," this ES-KES joint symposium explores the growing burden of diabetes. Professor Jason K. Kim will begin the session with a talk on Precision medicine for chronic metabolic diseases. Following this, Professor William Herman will examine the cost-effectiveness of diabetes prevention, and Professor Soo Heon Kwak will highlight the challenges and opportunities of genetic information in precision medicine. This session will provide key insights for advancing diabetes management and prevention.

The ESE-KES Joint Symposium aims to foster mutual friendship and collaboration between two societies. This year’s symposium will focus on Glucocorticoid-Induced Adrenal Insufficiency, featuring two expert speakers from ESE (Eystein Husebye and Alessandro Prete) who will present the latest updates from newly published guidelines. This year’s symposium will be conducted in an interactive format with live Q&A sessions to enhance engagement and discussion. Additionally, Mi Kyung Kim from KES will share insights on the Korean status and data related to this condition. This session promises to provide valuable knowledge and diverse perspectives to enhance clinical practice.